Save this technology
close
Save to Existing Project
Save to a New Project
SJ-BRV Antiobesity Immunodrug_SJ BIOMED Inc
Korea Health Industry Development Institute (KHIDI) South Korea flag South Korea
Abstract ID:
SJ-BRV is a novel therapeutic and prophylactic immunodrug for the treatment and prevention of obesity
Contact Yong U Kim
Participants
You
Email me a copy of this message

SJ-BRV is novel therapeutic and prophylactic immunodrug for the treatment and prevention of obesity by controlling lipid metabolism in a stage of storage. The key to the SJ-BRV vaccine is to trick the immune system into making antibodies against self antigens. SJ-BRV works by eliciting antibodies that block the binding of lipids in receptors in the adipose tissue thus preventing lipid storage in the adipose tissue.


-          Working on process development on candidate protein SJ-BRV


-          Formulation Study in preparation


-          Preparing non-clinical toxicity study design and clinical design

FEATURED
Last Updated Jul 2013
Technology Type THERAPEUTIC
Phase of Development CLINICAL TRIALS
GOVERNMENT INSTITUTE

Opportunity Contact